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Zoonosis Update
Tuberculosis is a term that encompasses various dis-eases caused by bacteria of the Mycobacterium tuber-
culosis complex, including M tuberculosis, M bovis, 
M africanum, and other mycobacterial species. Whereas
M tuberculosis infection is largely spread from human to
human, M bovis infection has been identified as a
zoonotic disease with most cases of human infection
attributable to animal sources. The mycobacteria other
than tuberculosis complex (MOTT), which includes 
M avium subsp avium and M avium subsp intracellulare
isolated from animals,1,2 has been isolated from
immunocompromised humans (ie, those with human
immunodeficiency virus [HIV] infection), but seldom
from immunocompetent humans.3 Recently, there has
been increased interest among public health officials in
drug-resistant strains of M tuberculosis, M bovis, and 
M avium because several have been isolated from HIV-
infected and nonimmunocompromised humans.4
Mycobacterium tuberculosis is the cause of most of
the cases of tuberculosis in humans. Worldwide, more
humans die as a result of tuberculosis each year than
from any other infectious disease.4 At present, more
than a third of the world’s population is infected with
tubercle bacilli and more people are dying as a result of
tuberculosis than ever in history. Ninety-five percent of
the tuberculosis cases are reported in developing coun-
tries, and it has been estimated that the disease results
in the deaths of 2 to 3 million people each year. 
Infection with M bovis has been reported in
humans5-10,a,b and causes pulmonary and extrapul-
monary disease.11,12 In the United States and other
developed countries, extrapulmonary M bovis infec-
tions in humans have been almost eliminated follow-
ing the introduction of food-production procedures
such as pasteurization of milk and routine carcass
inspection.11,13 However, M bovis infection commonly
occurs in less-developed countries and in specific
demographic groups within developed countries in
which consumption of unpasteurized dairy products is
practiced. Although there is no active surveillance pro-
gram for human cases of M bovis infection in the
United States, most of the reported cases appear local-
ized to states with large immigrant populations from
countries with recognized M bovis infections in live-
stock.10,a,b For example, 7% of mycobacterial isolates
from 1,931 cases of tuberculosis in San Diego were
identified as M bovis. These infections were associated
with ingestion of raw dairy products; 53% of these
patients had extrapulmonary disease,10,14 and 33% of
isolates obtained from children were M bovis.10,14 
Contact with infected animals is another source of M
bovis infection for humans and is a recognized hazard for
abattoir workers, veterinarians, and livestock handlers.5-
7,11,15-17 Among such workers who developed the disease,
aerosol transmission was considered the most likely
route of infection, but there are many occasions on which
infection had been spread via cuts and abrasions (eg,
butcher’s wart).16 Although many of the primary non-
aerosol sources of M bovis infection in humans have been
removed in industrialized countries, there has been an
increase in the number of cases of pulmonary infection
with M bovis, which may be due to several factors: the
lung is the usual site of postprimary M bovis infection,
regardless of the site of the primary lesion; cases of pul-
monary M bovis infection may be the result of reactiva-
tion of previously quiescent (ie, nonclinical) primary
lesions; and infection may be the result of human-to-
human aerosol transmission.16 Finally, aerosol transmis-
sion of M tuberculosis from humans to animals has been
reported.18,19 The disease has been reported in elephants,
nonhuman primates, and several other species.18-22,b
The reemergence of M bovis infection in captive
and free-ranging wild animals, with subsequent trans-
mission of infection to domestic animals, is of concern
to livestock producers and regulatory officials in the
United States and in several other countries of the
world.23-26 In Michigan, the detection of tuberculosis in
deer and other wild animals and the transmission of 
M bovis infection to beef and dairy herds have threat-
ened the export of breeding stock and semen to other
states and to countries outside the United States.26
When an outbreak of tuberculosis in cattle is reported
within a state, federal disease control officials remove
the state’s accredited-free status, causing economic
hardships for the state’s livestock industries.
With the effects of tuberculosis on animal health
and zoonotic implications, eradication and control of
disease caused by the bacteria that compose the
M tuberculosis complex are high priorities. Despite
efforts to control tuberculosis since its recognition in
antiquity, the disease continues to be a problem in both
human and animal populations.
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Etiology
Bacteria of the M tuberculosis complex are aerobic,
nonmotile, non–spore-forming, slow-growing, acid-fast
bacilli. Because they are slow growing, isolation of the
bacteria can require 3 to 8 weeks of incubation.27 Results
of experimental studies28,29 indicate that the strain of the
organism, dose of the organism, route of inoculation,
and prevailing conditions for growth of the organism
may influence the time required to produce disease.
The natural and acquired immune response mech-
anisms of a host are often successful in limiting prolif-
eration of tubercle bacilli and the development of pro-
gressive disease.29 The susceptibility of certain animal
species to different types of tubercle bacilli is variable.
Nonhuman primates, swine, cats, and dogs are suscep-
tible to M tuberculosis. Ruminants are quite resistant to
infection by M tuberculosis; however, this organism
may induce responses to M bovis purified protein
derivative (PPD) tuberculin. Other mycobacterial
infections including those involving M avium complex
(M avium-M intracellulare-M scrofulaceum), M kansasii,
M fortuitum, and M avium subsp paratuberculosis may
induce skin sensitivity to tuberculin, but do not usual-
ly induce progressive pulmonary disease in cattle and
other animals.2 Cattle are susceptible to M bovis, yet
they are comparatively resistant to infection with 
M tuberculosis.30 Moreover, laboratory animals such as
guinea pigs and rabbits are susceptible to M bovis,
whereas chickens are resistant to that organism; this
difference in observed susceptibilities may be associat-
ed with differences in body temperature.31
Pathogenesis
Mycobacterium bovis infection first results in the for-
mation of a primary focus, which is usually located in the
lungs.31-33 In mammals, lymphatic drainage from the pri-
mary focus leads to the formation of caseous lesions in an
adjacent lymph node; this lymph node lesion, together
with the primary focus, is known as the primary com-
plex. This primary complex seldom heals in animals. 
Results of experimental investigations30-33 involv-
ing exposure of animals to M bovis via IV, intratracheal,
and IP injection and via the oral route have indicated
that the nature and extent of the resultant disease vary
with the route of exposure. In cattle and other animals,
aerosol spread of tubercle bacilli frequently leads to
involvement of lungs and thoracic lymph nodes,
whereas exposure by ingestion of contaminated food
and water often results in primary foci in lymph tissues
associated with the intestinal tract.30
At sites of localization of the organisms, granulomas
form and develop into tumor-like masses called tubercles
in advanced cases.29 Because of the continued growth of
the organisms, these tubercles often enlarge to a consider-
able size. Large masses may develop on the serous mem-
branes of the body cavities. As the granulomas increase in
size, necrosis of their central portions may occur. Finally,
these central portions are reduced to caseous masses,
which have a tendency to undergo mineralization or liq-
uefaction. In mammals, tubercles may become enclosed
in dense fibrous tissue and the disease becomes arrested. 
Advanced lesions associated with clinical disease
include caseous nodules or cavities with liquefaction. 
Bacilli are transferred from the primary foci via lymph
and blood vessels; they lodge in other organs and tis-
sues, thereby establishing sites of additional tubercles.
When the bloodstream is invaded by numerous tuber-
cle bacilli from a local lesion, many tubercles develop
in the major organs (such as the lungs). The acute
form of generalized infection (known as miliary tuber-
culosis) is often rapidly fatal. If small numbers of bacil-
li enter the circulation from the primary complex, a
few isolated lesions develop in other organs; these
widely distributed lesions may become encapsulated
and remain small for extended periods, usually causing
no detectable clinical signs of disease.30 The progres-
sion of the disease from early infection of macrophages
to the development of caseous nodules that undergo
calcification and liquefaction, as well as the regression,
progression, or generalized spread of lesions, depends
on the interrelation of the immune response of the host
and the proliferation of the bacilli in macrophages.29,31
The disease can take months to develop.
Epidemiology
The M tuberculosis complex is known to infect a
wide variety of warm-blooded animals. Although occa-
sional cases of M tuberculosis have been reported in ani-
mals such as cats, dogs, and elephants, the sources of
these infections have commonly been traced to infect-
ed humans who have exposed susceptible animals to
infection. In animals, most mycobacterial infections
that are reported involve M bovis; therefore, infection
with M bovis is of public-health and economic impor-
tance. 
Several mammalian species are known to be suscep-
tible to infection with M bovis, including hoofed mam-
mals (Artiodactylae and Perissodactylae), marsupials,
carnivores, primates, pinnipeds, lagomorphs, rodents,
and other species. In addition to mammals, some avian
species are also susceptible to infection, including parrot-
like birds (Psittacciformes), rock doves, and North
American crows. Humans are also susceptible to M bovis,
and there are numerous instances of human infection
resulting from contact with infected animals.5-7,16,17,34-37
Throughout the world, the most commonly recognized
hosts for M bovis are domesticated bovids. However, in
recent years, several wildlife reservoir hosts have been
identified, including brushtail possums in New
Zealand,38,39 European badgers in the United Kingdom,40,41
white-tailed deer in Michigan,42,43 and Cape buffalo44 and
several antelope species in South Africa.36 Other species,
such as elephants45 and rhinoceros,7,17 have been identi-
fied as hosts for M bovis infection in captivity. Although 
M bovis infection may be detected in other species, most
of those affected animals are considered to be spillover
hosts that require external sources of infection to main-
tain disease in their populations.
There are several routes of transmission for 
M bovis infection, but the primary routes of infection
are via the respiratory and gastrointestinal tracts.
Respiratory transmission via the inhalation of conta-
minated aerosols or fomites is the most efficient form
of transmission, requiring a low number of organisms
as an infective dose.32 Respiratory transmission has
been detected in herding animals, such as domestic
cattle,16,32 feral water buffalo,46 and African cape buffa-
0301ZooUp.qxd  2/9/2004  9:50 AM  Page 686
JAVMA, Vol 224, No. 5, March 1, 2004 Vet Med Today: Zoonosis Update 687
lo,44 and in captive herds of various cervid species.47-49
Transmission of M bovis via inhalation appears to be
effective in wildlife species that are kept in confine-
ment in zoos7 and in free-ranging wildlife species that
maintain social or familial groups in underground
dens, such as European badgers in the United
Kingdom40 and brushtail possums in New Zealand.38
Furthermore, respiratory transmission of M bovis has
been detected in wildlife populations during periods
when normal behaviors become altered (for whatever
reason) and result in more frequent direct contact
between animals, such as that which occurred among
white-tailed deer in Michigan in association with
winter feeding.26,50
Although respiratory transmission is the most
important route of infection in groups of animals that
remain in close contact, indirect transmission via feed
contamination is another important route. For oral
transmission to be accomplished, an uninfected animal
has to consume feed or water contaminated with
mucous or nasal secretions, feces, or urine that contain
the infective organisms or receive milk from an infect-
ed dam; therefore, M bovis must be able to survive out-
side an infected host for sufficient time to be ingested
by another animal. The environmental survival of 
M bovis is reduced by dessication, exposure to sunlight,
and high temperature. Results of experimental studies
have indicated that M bovis can survive for < 4 days on
cotton strips51 and for as much as several months in
feces52-55 or in animal carcasses that remain out in the
field in South Africa.56 Oral transmission of M bovis has
been detected in several species: in cattle that graze
pastures contaminated with the organism57-60; in feral
swine in Australia61 and Hawaii62 that scavenge among
infected animal carcasses; in wild carnivores in Africa,
New Zealand,63,64 and North America65; and in dogs and
cats66-68 that consume contaminated milk or scavenge
contaminated carcasses. Consumption of infected
feeds has also been implicated in interspecies disease
transmission in which direct contact between species
was not evident (eg, the transmission of 
M bovis between white-tailed deer and cattle in
Michigan).69
Other routes of infection for M bovis have been
identified. Transmission through biting has been iden-
tified in black-footed ferrets in New Zealand63,70 and in
domestic cats.71 Vertical transmission has also been
identified in some species, but many cases of what has
appeared to be vertical transmission may be a result of
infection via aerosolization of organisms from infected
parent to offspring living in close quarters (eg, animal
dens), direct contact associated with grooming of off-
spring by infected mothers, or consumption of conta-
minated milk.72
Outbreaks of M bovis infection and endemic infec-
tion have been reported in animal populations.
Outbreaks are characterized by a rapid increase in
infection rate over a short period within a population
of animals; these can occur with the introduction of
infected animals to a population (eg, a cattle herd) that
has susceptible animals with the capacity for spreading
the disease among herd mates. Such explosive increas-
es in numbers of cases of infection are often easily
identified through routine surveillance procedures that
detect increases in the prevalence or incidence of infec-
tion, or as a result of the identification of sick animals
that are not included in surveillance programs. An
example of the latter is the detection of M bovis infec-
tion in free-ranging white-tailed deer in Michigan that
was recognized after a hunter submitted a carcass with
suspicious lesions to the state’s Department of Natural
Resources for investigation.42
Endemic mycobacterial infections are character-
ized by low rates of infection and have also been
reported in animal populations. The extent of the dis-
ease is not sufficient to affect the survival of the popu-
lation, but is sufficient to continue transmission of
infection within the populations.73 However, low rates
of infection may be below detectable levels for some
surveillance methods; the infection may be detected
only when circumstances change to increase the num-
ber of cases of disease in the population or when a
highly susceptible dead-end host is affected by infec-
tion from an endemically infected host species, with
dramatic effect. These problems associated with detec-
tion of low rates of infection must be taken into con-
sideration when evaluating the effectiveness of any 
surveillance program.
Clinical Findings
Clinical signs of tuberculosis vary depending on
the extent and location of the lesions. Detection of
enlarged superficial lymph nodes provides a useful
diagnostic sign, whereas small lesions located in deep
lymph nodes are of little or no value in establishing a
clinical diagnosis. The principal sign of tuberculosis is
wasting or emaciation that develops despite good
nutrition,30 and other general signs include weakness,
anorexia, dyspnea, and low-grade fluctuating fever. In
mammals, the organs of the thoracic cavity are usually
involved; when the lungs are extensively affected, an
intermittent hacking cough is commonly detected,
mainly after exercise. 
Diagnosis
Clinical diagnosis of tuberculosis is usually possi-
ble only after the disease has reached an advanced
stage and, with the exception of miliary tuberculosis, is
dependent on the site of lesions. At the time of diag-
nosis, most infected animals are shedding bacilli and
are a source of infection for other animals.
Antemortem evaluations are a critical component
of tuberculosis control programs throughout the
world. At this time, one of the most reliable and prac-
tical methods of diagnosis (albeit tentative) in domes-
tic animals is assessment via the tuberculin skin test.
Animals infected with mycobacteria are allergic to the
proteins contained in tuberculin and develop charac-
teristic delayed-type hypersensitivity reactions when
exposed to those proteins. The deposition of tuber-
culin intradermally in the deep layers of the skin 
usually elicits a local reaction characterized by inflam-
mation and swelling in infected animals, whereas such
reactions at the injection site fail to develop in unin-
fected animals. The sensitivity and specificity of the
intradermal test often depend on the field conditions,
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prevalence of infection, and other factors.30,74 The intra-
dermal tuberculin skin test may not be effective or
practical for use in all species, but has been accepted by
the USDA for identification of M bovis in cattle, bison,
goats, and captive cervids.75
At present, most countries use M bovis for the
preparation of PPD tuberculin for veterinary use; heat-
concentrated synthetic-medium old tuberculin is infre-
quently used. The use of PPD tuberculin is preferable
because it is easier to standardize and more specific
than old tuberculin and is particularly useful in com-
parative tuberculin tests used to differentiate responses
caused by M bovis or M tuberculosis and those induced
by other mycobacteria. Most countries use PPD tuber-
culin at a dose of 0.1 mL (ie, 0.1 mg of protein) con-
taining 5,000 tuberculin units in mammals and 0.05 mL
containing 2,500 tuberculin units in chickens. When
testing for avian tuberculosis, an M avium-PPD tuber-
culin must be used because animals infected with 
M avium react less to tuberculin made from the culture
filtrate of M bovis.30
In the United States, 2 specific skin tests are serially
applied to livestock herds for diagnosis of tuberculosis.
Large mammals such as cattle, bison, or deer are usually
injected in 1 of the folds at the base of the tail or in skin
of the cervical region (the caudal fold test); swine are
injected in the skin behind the ear or vulva, and chickens
are injected in the skin of the wattle. The injection sites
are examined by observation and palpation for charac-
teristic swelling 48 hours after injection for swine and
chickens and 72 hours after injection for cattle, sheep,
and goats.28,30,76 In general, animals for which test results
are positive or suspect are removed from the farm and
examined post-mortem for confirmation of mycobacteri-
al infection, depending on federal and state testing regu-
lations, which vary with species or the specific circum-
stances under which testing was undertaken. In cattle
that are suspected to have M bovis infection, the compar-
ative cervical skin test is administered by another caudal
fold test. The comparative cervical skin test is performed
by injecting biologically balanced M avium and M bovis
PPD tuberculins into separate sites in the skin of the
neck. The injection sites are examined by observation
and palpation. The differences in the size of the resultant
skin responses are compared on a graph, which indicates
whether the observed tuberculin sensitivity is caused by
infection with M bovis rather than infection with 
M avium subsp avium or M avium subsp paratuberculo-
sis.76 These results are then used to classify animals as
negative for infection (the response to the test is nega-
tive), suspected to have infection (the response to the test
is unclear), or reactor (the response to the test is posi-
tive). Although skin tests are useful tools in tuberculosis-
testing programs, they have the drawback of requiring
the individual performing the test to visit a production
facility or premises on which the animals are kept on 2
occasions: 1 to administer the tuberculin, and another to
assess the results of the test. Other diagnostic methods
that rely on cellular immune response and are performed
in vitro (such as lymphocyte blastogenic assays or 
γ-interferon tests) have been developed and used, with
results that are comparable to those obtained with intra-
dermal tests.77-79 A commercially available γ-interferon
test for cattlec has been recommended for use as a sup-
plemental diagnostic test for M bovis infection in cattle
herds.80 Recently, a protein (referred to as ESAT-6) has
been identified in the early phase of M bovis infection in
cattle.81,82 This may be important in the early detection of
tuberculous animals, before results of other tests are
found to be positive. However, immunologic tests have
been found to be unreliable in some species (eg, ele-
phants); isolation of the causative agent is then necessary
for diagnosis.21,83
Mycobacterial culture is still considered to be the
gold standard by which to confirm a diagnosis of
tuberculosis. Because of the slow growth of M tubercu-
losis complex bacilli, culture results are usually
obtained after 3 to 6 weeks. Recently, polymerase chain
reaction techniques have been reported to be useful in
the diagnosis of M tuberculosis and M bovis.21,22,68 A DNA
probe has been developed for identifying M bovis in
formalin-fixed, paraffin-embedded tissues, and results
of this analysis are available in a few days84; recently, a
modification of this polymerase chain reaction assay
was used to detect M avium.85
The development of molecular techniques for dif-
ferentiating strains of M bovis, such as DNA fingerprint-
ing (restriction fragment length polymorphism), has
been useful in outbreak investigations in animals and
humans to identify potential sources of infection or
relatedness of strains.10,18,68,86,87 By use of this technique,
the restriction fragment length polymorphism pattern of
an isolate of M bovis from an elderly Michigan resident
matched the unique pattern of the deer and cattle strain
that was circulating in the northeastern portion of the
Lower Peninsula of Michigan; this isolate had not previ-
ously been detected in a human in Michigan since rou-
tine speciation of isolates began in 1994. Although mul-
tiple exposure possibilities were explored, the conclu-
sion of the epidemiologic investigation conducted by the
Michigan Department of Community Health was that
exposure to deer from the endemically infected area of
Michigan was the most probable source of infection for
this patient.37 Although DNA fingerprinting is a useful
tool, the tests must be conducted under carefully con-
trolled conditions to avoid contamination and false-pos-
itive findings. More importantly, results of these tests do
not indicate the source and direction of the infection (ie,
results of the test cannot indicate which of 2 infected
populations was the source of infection for the other).
Control
Control programs for tuberculosis in animals are
primarily focused on control of infection with 
M bovis. These programs can be considered as having 4
components: prevention, treatment, eradication, and
surveillance. Disease prevention primarily focuses on
reducing opportunities for animals to be exposed to
the pathogen of concern and reducing the likelihood
that an exposed animal will become infected after
exposure. On cattle farms, the major source of M bovis
is infected cattle that either reside on the farm or are
introduced to the herd from another facility. Basic herd
hygiene and biosecurity practices (eg, routine testing
for tuberculosis and quarantine of imported animals,
manure management, and maintenance of feed and
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water hygiene) have been found to reduce the risks of
spread of M bovis on cattle farms.69,88-90
It has been necessary to establish population con-
trol measures for wild reservoir animals (ie, possums,
badgers, and white-tailed deer) that may shed tubercle
bacilli and contaminate feed and water. Although the
main reservoir of M bovis is cattle, there are several
instances in which wildlife reservoirs (including
European badgers,91,92 brushtail possums,93 deer,42,94,95
African Cape buffalo,25,44,96 and wild boar97) have been
important sources of infection for cattle. Reservoir ani-
mals infected with tubercle bacilli that interact with
cattle may be the source of herd infections and signifi-
cant production losses.25,69
The BCG (Bacillus of Calmette and Guerin) vac-
cine has been used in humans in some countries in
which tuberculosis is prevalent in the population.
Unfortunately, the BCG vaccine does not completely
prevent infection in cattle or other animals28,98; more-
over, vaccinated animals yield positive results on the
tuberculin skin test, which precludes the use of the
vaccine in the United States or other countries with
eradication programs. In several countries where
M bovis infection has been reported in wild animals, a
BCG vaccine has been evaluated as an immunizing
agent.61,99-101 It should be noted that there is consider-
able interest in the development of new DNA vaccines;
however, they have not been accepted for use in food-
producing animals.
Until the discovery of the antituberculosis drug
isonicotinic acid hydrazide, there was no practical
treatment for tuberculosis. Elephants receiving isoni-
cotinic acid hydrazide along with rifampicin or etham-
butol have successfully recovered from tuberculosis
after 6 months of treatment. In Brazil and South Africa,
investigators have suggested that it is feasible to treat
cattle with isoniazid, and guidelines have been devel-
oped for treatment of infective animals with antituber-
culosis drugs, but the treatment of tuberculosis in cat-
tle is not allowed in the United States nor in many
other countries.42 When treatment is attempted, appro-
priate regimens must be followed; for elephants with 
M tuberculosis-complex infections, this involves
administration of 360 doses of 3 drugs within a 15-
month period, with concurrent testing for serum drug
concentrations.102
In domestic livestock herds, depopulation is an
effective way of removing M bovis from a livestock oper-
ation. After a waiting period (12 months in the United
States) in which livestock is not allowed on the depop-
ulated site, the facility can be restocked. Although
depopulation is an effective tool for controlling tuber-
culosis for the livestock industry as a whole, the effects
can be devastating both financially and emotionally to
individual farmers. As an alternative to depopulation of
herds in the United States, the USDA allows regulatory
agencies to develop herd-specific test-and-slaughter
programs for individual livestock operations.101
Depending on the reservoir species involved, erad-
ication of M bovis infection in wildlife can be highly
problematic. The size and distribution of wildlife pop-
ulations are often unknown, the extent of disease in
the population can be difficult (if not impossible) to
estimate accurately, and aspects of animal behavior
associated with the distribution of the disease in the
wild may be unclear. The control of tuberculosis in
cervids and other wild animals is limited to population
control because intradermal testing of those animals is
not practical. Population control is usually exercised
through trapping and removal programs,59 directed
hunts to reduce animal numbers,25 or provision of
incentives to hunters (ie, unlimited hunting permits
and increased duration of the hunting season) to
increase the number of animals removed during the
hunting season.26,43 In addition to population control,
wildlife behavior modification has been used as a tool
to reduce the spread of the disease in the wildlife pop-
ulation. In the outbreak of M bovis in free-ranging
white-tailed deer in Michigan, large-scale winter feed-
ing in 1 area of the state that had continued for decades
had dramatically increased the numbers of deer in the
area and created conditions in which large numbers of
normally timid animals would congregate around feed
piles.42,50 After the discovery of tuberculosis in wildlife,
bans were placed on feeding and baiting of animals in
areas where they may gather during cold weather or
other conditions associated with limited food supply.50
After these measures had been applied over a 6-year
period, the apparent prevalence of tuberculosis in deer
in a 12-county area in Michigan decreased by 50%.26
A final component of any tuberculosis control and
eradication program is routine surveillance to detect
any changes in development of the disease. This
includes antemortem testing and slaughter surveil-
lance of livestock and captive animal species.
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